Analytics

Equity Analytics

On the record this week: what the Street published, what insiders filed, and what reports next.

Equity Analytics/JAZZ

JAZZ

Jazz Pharmaceuticals plc

Healthcare - IE - listed in USD

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), headquartered in Dublin, Ireland and founded in 2003, develops and commercializes innovative biopharmaceutical products for serious diseases with significant unmet needs, primarily in neuroscience an…

HQ: Dublin, DU, Irelandwww.jazzpharma.com

USD245.80+2.21%vs prev. close

Market snapshot

Price

USD245.80

Daily move

+2.21%

P/E

16.8

EPS TTM

14.60

Dividend yield

—

Beta

0.36

Market cap

16.0B

Price history

JAZZ price

USD

VolumeLog scale

No price history available

Next earnings

No upcoming earnings report scheduled in the next 6 months.

Peer comparison

Company	Ticker	Industry	Mkt cap (USD bn)	P/E	Div yld	1W	1M	3M	6M	1Y	YTD
Jazz Pharmaceuticals	JAZZ	Biotechnology	16.0	16.8	—	-0.4%	-1.3%	+6.6%	+37.7%	+91.3%	+44.6%

Subscribe to Equity Analytics to compare JAZZ with its closest peers

Sector-matched peer set with side-by-side valuation, dividend and performance over every window.

View plans

Ask Ashenden

One question, one concise answer grounded in Ashenden research.

Built on Ashenden research and our own data. Answers are AI-generated: they can be wrong or incomplete — check anything you would act on.